Selenium Attenuates Radiation Colitis by Regulating cGAS‐STING Signaling
Xuefeng Qian,
No information about this author
Haoqiang Lai,
No information about this author
Haimei Zhang
No information about this author
et al.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 30, 2024
Abstract
Radiation
colitis
is
one
of
the
most
common
complications
in
patients
undergoing
pelvic
radiotherapy
and
there
no
effective
treatment
clinic.
Therefore,
searching
for
agents
radiation
urgently
needed.
Herein,
it
found
that
essential
element
selenium
(Se)
protective
against
through
inhibiting
X‐ray‐induced
apoptosis,
cell
cycle
arrest,
inflammation
with
involvement
balancing
generation
reactive
oxygen
species
after
irradiation.
Mechanistically,
Se,
especially
nanoparticles
(SeNPs),
induced
selenoprotein
expression
then
functioned
to
effectively
restrain
DNA
damage
response,
which
reduced
intestinal
injury.
Additionally,
SeNPs
also
restrained
cyclic
GMP‐AMP
synthas
(cGAS)‐
stimulator
interferon
genes
(STING)‐TBK1‐IRF3
signaling
pathway
cascade,
thereby
blocking
transcription
inflammatory
cytokine
gene,
IL‐6
TNF‐α,
thus
alleviating
inflammation.
Moreover,
inducing
expression,
such
as
GPX4,
vivo
can
regulate
microenvironment
immunity
gut
microbiota
attenuate
radiation‐induced
by
oxidative
stress
maintaining
homeostasis.
Together,
these
results
unravel
a
previously
unidentified
modulation
role
but
suppressing
cGAS‐STING‐TBK1‐IRF3
cascade.
Language: Английский
Mitochondria‐Modulating Liposomes Reverse Radio‐Resistance for Colorectal Cancer
Junmei Li,
No information about this author
Yuhong Wang,
No information about this author
Wenhao Shen
No information about this author
et al.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(18)
Published: March 23, 2024
Complete
remission
of
colorectal
cancer
(CRC)
is
still
unachievable
in
the
majority
patients
by
common
fractionated
radiotherapy,
leaving
risks
tumor
metastasis
and
recurrence.
Herein,
clinical
CRC
samples
demonstrated
a
difference
phosphorylation
translation
initiation
factor
eIF2α
(p-eIF2α)
activating
transcription
4
(ATF4),
whose
increased
expression
initial
X-ray
irradiation
led
to
resistance
subsequent
radiotherapy.
The
underlying
mechanism
studied
radio-resistant
CT26
cells,
revealing
that
incomplete
mitochondrial
outer
membrane
permeabilization
(iMOMP)
triggered
key
for
elevated
p-eIF2α
ATF4,
therefore
radio-resistance.
This
finding
guided
discover
metformin
2-DG
are
synergistic
reversing
radio
inhibiting
ATF4.
Liposomes
loaded
with
(M/D-Lipo)
thus
prepared
enhancing
radiotherapy
CRC,
which
achieved
satisfactory
therapeutic
efficacy
both
local
metastatic
tumors
radio-resistance
preventing
T
lymphocyte
exhaustion.
Language: Английский
Radioresistance in rectal cancer: can nanoparticles turn the tide?
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 30, 2025
Abstract
Rectal
cancer
accounts
for
over
35%
of
the
worldwide
colorectal
burden
representing
a
distinctive
subset
cancers
from
those
arising
in
colon.
Colorectal
exhibit
continuum
traits
that
differ
with
their
location
large
intestine.
Due
to
anatomical
and
molecular
differences,
rectal
is
treated
differently
colon
cancer,
neoadjuvant
chemoradiotherapy
playing
pivotal
role
control
locally
advanced
disease.
However,
radioresistance
remains
major
obstacle
often
correlated
poor
prognosis.
Multifunctional
nanomedicines
offer
promising
approach
improve
radiotherapy
response
rates,
as
well
increase
intratumoral
concentration
chemotherapeutic
agents,
such
5-Fluorouracil.
Here,
we
revise
main
differences
between
tumors,
exploring
complex
orchestration
beyond
most
reported
literature
therapy
rates.
Graphical
Language: Английский
Establishment and biological characterization of radioresistant colorectal cancer cell lines
Tianyin Qu,
No information about this author
Qing Dai,
No information about this author
Jing Leng
No information about this author
et al.
FEBS Open Bio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 8, 2025
Radiotherapy
resistance
is
a
major
cause
of
recurrence
and
metastasis
in
colorectal
cancer
(CRC).
We
established
radiotherapy-resistant
cell
lines
to
explore
the
molecular
mechanisms
radiotherapy
CRC.
HT29
HCT116
cells
were
subjected
repeated
irradiation
at
2
Gy
establish
these
lines.
CCK-8
assay,
colony
formation,
xenograft
tumor
experiments
used
detect
radiosensitivity
cells.
DNA
damage
repair
proteins,
GSH
content,
intracellular
ROS
also
assayed
parental
resistant
successfully
HT29R
HCT116R
radioresistant
after
fractionated
irradiation,
showed
significant
tolerance
further
compared
with
stronger
capacity
for
repair.
Meanwhile,
ionizing
radiation
significantly
reduced
but
had
no
effect
on
content
These
results
demonstrate
that
by
method
continuous
Gy.
This
provides
basis
exploration
mechanism
resistance.
Language: Английский
Oral Antioxidant-Engineered Probiotics for the Treatment of Radiation-Induced Colitis
ACS Applied Materials & Interfaces,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 10, 2025
Radiation
colitis
is
an
inflammatory
response
induced
by
damage
to
colonic
tissue
from
radiation
therapy
that
primarily
affects
patients
undergoing
abdominal
or
pelvic
treatments.
In
this
study,
we
designed
a
selenium-loaded
probiotic
(EcN-Se@SA)
encapsulated
in
sodium
alginate
gel
for
the
oral
treatment
of
colitis.
Selenium
nanoparticles
(Se
NPs)
exhibit
antioxidant,
anti-inflammatory,
ferroptosis,
and
repair-promoting
properties.
To
enhance
therapeutic
efficacy
Se
NPs
radiation-induced
colitis,
combined
with
Escherichia
coli
Nissle
1917
them
hydrogel.
The
resulting
EcN-Se@SA
formulation
not
only
withstands
gastric
acid
intestinal
fluids
but
also
remains
colon
cecum
extended
periods.
Oral
administration
attenuates
X-ray-induced
mice
through
its
antioxidant
anti-inflammatory
effects,
macrophage
reprogramming,
inhibition
ferroptosis
histiocytes.
This
work
introduces
promising
candidate
Language: Английский
Myofibroblasts-targeting Extracellular Vesicles as Drug Delivery for Cardiac Fibrosis Therapy
Yi Wang,
No information about this author
Hao Jiang,
No information about this author
Qing Chen
No information about this author
et al.
Biomaterials Research,
Journal Year:
2025,
Volume and Issue:
29
Published: Jan. 1, 2025
Current
pharmacological
treatments
for
cardiac
fibrosis
are
often
limited
by
their
efficacy
and
specificity,
leading
to
marked
side
effects.
Fibroblast
activation
protein
(FAP)
is
specifically
expressed
on
activated
myofibroblasts
(myoFbs)
but
not
resting
fibroblasts,
making
it
a
promising
target
therapy.
In
this
study,
we
engineered
extracellular
vesicles
(EVs)
conjugated
with
an
anti-FAP
single-chain
variable
fragment,
termed
αFAP-EVs,
which
myoFbs.
Our
results
demonstrated
that
αFAP-EVs
successfully
targeted
myoFbs
in
vitro
localized
fibrotic
regions
isoproterenol-induced
mouse
hearts
vivo.
To
further
enhance
delivery
efficiency,
were
combined
clodronate-loaded
liposomes
(αFAP-EL@CLD)
reduce
liver
accumulation
improve
site
targeting.
αFAP-EL@CLD
loaded
cholesterol-methylated-
phosphorothioate-modified
miR-29b
(Agomir-29b)
or
the
transforming
growth
factor
beta
1
receptor
inhibitor
GW788388
significantly
inhibited
myoFb
reduced
models.
Importantly,
these
drug-loaded
exhibited
high
therapeutic
minimal
systemic
toxicity,
attributed
stability
capabilities.
These
findings
suggest
candidates
therapy,
offering
foundation
future
clinical
applications.
Language: Английский
Investigating the role of disulfidptosis related genes in radiotherapy resistance of lung adenocarcinoma
Xiaoxia Pan,
No information about this author
Hongyan Qian,
No information about this author
Zhouna Sun
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 23, 2024
Background
Radiotherapy
resistance
is
an
important
reason
for
high
mortality
in
lung
cancer
patients,
but
the
mechanism
still
unclear.
Dysregulation
of
cell
proliferation
and
death
plays
a
crucial
role
onset
progression
adenocarcinoma
(LUAD).
In
recent
times,
novel
form
cellular
demise
called
disulfidptosis,
has
attracted
increasing
attention.
However,
it
unclear
whether
radiation-related
disulfidptosis
genes
have
prognostic
LUAD.
Methods
A
complete
suite
bioinformatics
tools
was
used
to
analyze
expression
significance
genes.
Afterward,
we
investigated
predictive
risk
signature
tumor
microenvironments
(TME),
somatic
mutations,
immunotherapies.
addition,
conducted
series
experiments
verify
differentially
expressed
radiotherapy
related
(DERRDGs)
vitro
.
Results
total
88
DERRDGs
were
found.
We
constructed
validated
model
based
on
PRELP,
FGFBP1,
CIITA
COL5A1.
The
enrichment
analysis
showed
DERRDG
affected
prognosis
by
influencing
(TME)
immunotherapy.
And
nomogram
promote
clinical
application.
q-PCR
confirmed
significant
differences
between
A549
irradiation-resistance
A549.
Finally,
western-blot,
IHC
staining,
small
interference
experiment
suggested
that
PRELP
may
be
potential
biomarker
resistance,
whose
low
associated
with
poor
outcomes
LUAD
patients.
Conclusion
This
study
reveals
possible
underlying
mechanisms
discovered
key
gene
which
helps
identify
new
biomarkers
provides
basis
future
research.
Language: Английский